Michela Emma Burlone

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

David J. Pinato, Rohini Sharma, Elias Allara et al. · Journal of Hepatology · 2016 · 417 citations · Full text

Medicine, Oncology, Pathology +14

B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)

Stefania Bruzzì, Salvatore Sutti, Gabriele Giudici et al. · Free Radical Biology and Medicine · 2018 · 132 citations · Full text

Medicine, Immunology, Pathology +11

Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma

Jessica Howell, Stephen R. Atkinson, David J. Pinato et al. · European Journal of Cancer · 2019 · 70 citations · Full text

Medicine, Molecular Biology, Oncology +14

Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment

Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi et al. · Hepatology · 2024 · 54 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study

Jessica Howell, David J. Pinato, Ramya Ramaswami et al. · Alimentary Pharmacology & Therapeutics · 2017 · 53 citations · Full text

Medicine, Oncology, Pharmacotherapy +17